» Articles » PMID: 28100216

Antispasmodic, Bronchodilator, Vasorelaxant and Cardiosuppressant Effects of Buxus Papillosa

Overview
Publisher Biomed Central
Date 2017 Jan 20
PMID 28100216
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The present research was carried out to investigate pharmacological properties of Buxus papillosa C.K. Schneid. (Buxaceae).

Methods: Buxus papillosa extracts of leaves (BpL), stem (BpS), roots (BpR) and BpL fractions: hexane (BpL-H), aqueous (BpL-A) also plant constituent, cyclomicrobuxine effect were studied in jejunum, atria, aorta and tracheal preparations from rabbit and guine-peg.

Results: Ca antagonistic effect of BpS, BpR, BpL-H, BpL-A and cyclomicrobuxine were conclusively suggested, when spontaneous contractions of rabbit jejunal preparation was relaxed along with subsequent relaxation of potassium chloride (80 mM) induced contractions. Ca antagonistic effect was further confirmed, when a prominent right shift like that of verapamil was observed in Ca concentration-response curves, drawn in a tissue pretreated with BpL (0.3-1.0 mg/mL). In rabbit tracheal tissues BpL, BpS, BpR, BpL-H and BpL-A produced a prominent relaxation in contractions induced by potassium chloride (80 mM) and carbachol (1 μm). When tested in rabbit aortic rings, BpL, BpS, BpR, BpL-H and BpL-A showed concentration-dependent (0.1-3.0 mg/mL) vasorelaxant effect against phenylephrine (1 μM) and high K-induced contractions. In isolated guinea-pig right atria, BpL, BpS, BpR, BpL-H and BpL-A suppressed atrial force of spontaneous contractions, with BpL-A being most potent.

Conclusions: Our results reveal that Buxus papillosa possesses gut, airways and cardiovascular inhibitory actions.

Citing Articles

Genomics approaches to synthesize plant-based biomolecules for therapeutic applications to combat SARS-CoV-2.

Sharma N, Muthamilarasan M, Prasad A, Prasad M Genomics. 2020; 112(6):4322-4331.

PMID: 32717321 PMC: 7381398. DOI: 10.1016/j.ygeno.2020.07.033.


In Vivo, Proteomic, and In Silico Investigation of Sapodilla for Therapeutic Potential in Gastrointestinal Disorders.

Ansari S, Khan A, Qazi N, Shah F, Naeem K Biomed Res Int. 2019; 2019:4921086.

PMID: 31886219 PMC: 6925776. DOI: 10.1155/2019/4921086.

References
1.
Nakano T, Terao S . Buxus alkaloids. IV. Isolation and structure elucidation of eight new alkaloids, cyclomicrophylline-A, -B, and -C, dihydrocyclomicrophylline-A and -F, cyclomicrophyllidine-A, dihydrocyclomicrophyllidine-A, and cyclomicrobuxine, from B. microphylla.... J Chem Soc Perkin 1. 1965; :4512-37. DOI: 10.1039/jr9650004512. View

2.
Polster P, Christophe B, Van Damme M, Houlliche A, Chatelain P . SR 33557, a novel calcium entry blocker. I. In vitro isolated tissue studies. J Pharmacol Exp Ther. 1990; 255(2):593-9. View

3.
Khan M, Khan A, Najeeb-Ur-Rehman , Gilani A . Gut and airways relaxant effects of Carum roxburghianum. J Ethnopharmacol. 2012; 141(3):938-46. DOI: 10.1016/j.jep.2012.03.039. View

4.
Shareef H, Rizwani G, Mandukhail S, Watanabe N, Gilani A . Studies on antidiarrhoeal, antispasmodic and bronchodilator activities of Operculina turpethum Linn. BMC Complement Altern Med. 2014; 14:479. PMC: 4295308. DOI: 10.1186/1472-6882-14-479. View

5.
FLECKENSTEIN A . Specific pharmacology of calcium in myocardium, cardiac pacemakers, and vascular smooth muscle. Annu Rev Pharmacol Toxicol. 1977; 17:149-66. DOI: 10.1146/annurev.pa.17.040177.001053. View